Principia Biopharma Funding & Investors
Principia Biopharma Inc. operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States.
principiabio.comTotal Amount Raised: $127,799,976
Principia Biopharma Funding Rounds
Series Unknown
$49,999,978
Series Unknown Investors
Mission BioCapitalSeries B
$15,300,000
Series B Investors
OrbiMedNew Leaf Venture PartnersMorgenthalerBaker Bros. AdvisorsSofinnovaSr OneSeries B
$50,000,000
Series B Investors
SofinnovaMorgenthalerNew Leaf Venture PartnersSr OneMission Bay CapitalOrbiMedSeries A
$12,500,000
Series A Investors
New Leaf Venture PartnersOrbiMedMorgenthalerMission Bay CapitalSr One
Funding info provided by Diffbot.